BiotechTube
Home/Bioptamers/Erika Molina, Ph.D.
EM

Erika Molina, Ph.D.

CEO

Bioptamers

Therapeutic Areas

Oncology

Bioptamers Pipeline

DrugIndicationPhase
Aptamer-Drug Conjugate PlatformOncologyPre-clinical
Aptamer-Radionuclide Conjugate PlatformOncologyPre-clinical
Aptamer-Immunotherapy PlatformOncologyPre-clinical

Leadership Team at Bioptamers

EM
Emerson Moretto, M.Sc.
CTO
View full Bioptamers profile